HOME >> MEDICINE >> NEWS
Potential prostate cancer treatment improvements discovered by researchers at Cedars-Sinai

In a study to be published in the April, 2006 issue of the British Journal of Urology International, researchers at Cedars-Sinai Medical Center have shown that Raloxifene, a drug commonly used to treat osteoporosis, has a potential clinical benefit in treating men with prostate cancer. This study has implications for the approximately 35,000 men who will die this year of advanced prostate cancer.

Prostate cancer is the leading cause of cancer and the second leading cause of cancer-related death among men living in the United States. Approximately one in six men will be diagnosed with prostate cancer during his lifetime. "We undertook this study because we desperately need new therapies for patients with advanced prostate cancer," said David B. Agus, M.D., research director of the Louis Warschaw Prostate Cancer Center at Cedars-Sinai and principal investigator of the study.

Since Raloxifene is a drug already on the market, researchers were able to move directly into a Phase II clinical trial. They identified the presence of the beta isoform of the estrogen receptor in prostate cancer tissue samples, then moved directly into studies of animals with human prostate cancer, and then onto human clinical trials. The entire process took only 2-3 years.

"It used to be that to show effectiveness through research studies, cancer drugs needed to shrink tumors by 50 percent," Agus said. "Now, the new way of thinking about the effectiveness of cancer drugs is whether they can slow cancer's growth, which ultimately may significantly benefit patients."

Through the study, patients were given a daily oral dosage of Raloxifene, and the disease and its symptoms were followed on a regular basis. Some of the patients in the clinical trial taking Raloxifene showed evidence of disease stabilization manifested by a slowing or stopping of the growth of their prostate cancer.

According to Ronald L. Shazer, M.D., primary author of the manuscri
'"/>

Contact: Cynthia Harding
cynthia.harding@cshs.org
310-423-4768
Cedars-Sinai Medical Center
21-Mar-2006


Page: 1 2

Related medicine news :

1. Potential heart benefit found in stem cells
2. Potential association between skin cancer cream and improvements of prematurely aged skin
3. Potential treatment for intracerebral hemorrhage under study
4. Potential pharmaceutical drugs in the field of cancer
5. Potential new treatment for insulin-dependent diabetes
6. Potential weak link between virus and liver cancer discovered
7. Conventional prognostic factors fail to explain better prostate cancer survival in most Asian men
8. Trial shows circulating tumor cells predict how prostate cancer patients do with chemotherapy
9. African-American men understimate risk of prostate cancer
10. Treatment for early prostate cancer associated with type of specialist seen
11. Nonhormonal drug reduces hot flashes in men treated for prostate cancer

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:7/1/2020)... ... July 01, 2020 , ... Dexur’s analysis ... OrthoColorado Hospital , Porter Adventist Hospital , and Sky Ridge Medical ... Hip & Knee Replacement. Dexur’s value analysis tracks a patient’s episode of care from ...
(Date:7/1/2020)... ... July 01, 2020 , ... The Society to Improve Diagnosis ... at the University of Massachusetts Medical School- Baystate and Ann Gaffey, RN, MSN, ... Board of Directors. Dr. Salvador and Ms. Gaffey’s service began in May and ...
(Date:6/28/2020)... ... June 26, 2020 , ... Medisend College of Biomedical Engineering ... and training that prepares graduates for professional careers as field service engineers and ... of Trustees. , Ms. Williams currently serves as Associate Vice Chancellor of Workforce ...
(Date:6/28/2020)... ... 26, 2020 , ... The Coronavirus pandemic created shortages in ... supplier of top-quality masks, sanitizers and thermometers, Trusted PPE is a woman and ... observed, “All of our masks are manufactured to medical standards in FDA-certified factories, ...
(Date:6/28/2020)... ... June 28, 2020 , ... World ... dedicates World Allergy Week, from June 28 to July 4, 2020, to the ... , COVID-19, short for “coronavirus disease 2019”, is a disease spreading around the ...
Breaking Medicine News(10 mins):
(Date:7/1/2020)... ... July 01, 2020 , ... The final entry deadline for ... Tuesday, July 28. , The International Business Awards are widely considered to ... more than 4,000 nominations from organizations in more than 70 nations. , All ...
(Date:6/28/2020)... ... June 27, 2020 , ... CPAP Store USA, known for its one of ... devices, is growing and expanding at a rapid rate. Today, CPAP store USA is ... CPAP Store Dallas, located at 3920 Rosemeade Parkway, Suite 150, Dallas, Texas 75287. , ...
(Date:6/25/2020)... (PRWEB) , ... June 25, 2020 , ... The Heritage ... have had zero cases of COVID-19. With over 100,000 positive cases of the coronavirus ... the senior citizens who reside at The Heritage Downtown, their family members, as well ...
Breaking Medicine Technology:
Cached News: